Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation

AM Miller, IB McInnes - Current pharmaceutical design, 2011 - ingentaconnect.com
Patients with chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic
lupus erythematosus, psoriasis and Crohn's disease have an increased atherosclerotic risk …
被引用次数：46 相关文章

Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation

A Miller, I McInnes - Current Pharmaceutical Design, 2011 - eprints.gla.ac.uk
Patients with chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic
lupus erythematosus, psoriasis and Crohn's disease have an increased atherosclerotic risk …

Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation

AM Miller, IB McInnes - Current pharmaceutical design, 2011 - pubmed.ncbi.nlm.nih.gov
Patients with chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic
lupus erythematosus, psoriasis and Crohn's disease have an increased atherosclerotic risk …

Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation.

AM Miller, IB McInnes - Current Pharmaceutical Design, 2011 - europepmc.org
Patients with chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic
lupus erythematosus, psoriasis and Crohn's disease have an increased atherosclerotic risk …

[引用][C] Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation: The Adverse Effects of Chronic Inflammation on Cardiovascular …

AM MILLER, IB MCINNES - Current pharmaceutical design …, 2011 - pascal-francis.inist.fr
Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation : The
Adverse Effects of Chronic Inflammation on Cardiovascular Health CNRS Inist Pascal-Francis …

[引用][C] Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation

AM MILLER, IB MCINNES - Current pharmaceutical design, 2011 - Bentham